C. Spirig

Type de document

Co-auteur

E.M. Zubler

J. Zeder

K. Zaman

R. Winterhalder

R. Von Moos

F. Tschurr

S.L. Sørland

T. Suter

K.M. Strassmann

M. Skelton

S, I Seneviratne

C. Schwierz

A. Schönenberger

C. Schnadt Poberaj

S.C. Scherrer

C. Schär

T. Ruhstaller

O. Rössler

C. Rochlitz

D. Rauch

J. Rajczak

C.C. Raible

M. Pickl

N. Peleg

A. Müller

I. Medhaug

M. Mayer

C. Marty

M. Mannhart-Harms

M.A. Liniger

S. Lerch

S. Kotlarski

R. Knutti

J. Huober

M. Hirschi

R. Herrmann

A.M. Hama

E.M. Fischer

A.M. Fischer

I. Feigenwinter

M. Fehr

S. Fatichi

M. Croci-Maspoli

B. Cliffe

A. Casanueva

P. Burlando

M. Bühlmann

S. Brönnimann

D.N. Bresch

U. Beyerle

M. Bavay

N. Ban

Date

Source

Serveur académique Lausannois (2)

Mot-clé

Days (2) administration (1) toxicité (1) thérapie (1) son (1) spectacle (1) secteur des services (1) sécurité (1) planification (1) information (1) analyse (1) dose (1) point (1) climat (1) procès (1) cancer (1) abords (agglomération) (1) taux (1) public (1) comptabilité (1) Development (1) Treatment (1) Cancer (1) Fictitious characters (1) Communication (1) Adaptation (1) Accounting (1) Methods (1) Scenarios (1) Will (1)

Documents écrit par C. Spirig (2) | parle de C. Spirig (0)

Climate Scenarios for Switzerland CH2018 – Approach and Implications

A.M. Fischer et al.

Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06).

C. Rochlitz et al. (2011)